ACT with SRC-3 KO Tregs also significantly increased Ifng and Cxcl9 in breast tumors compared to ACT with wild-type Tregs (Fig. 5 I and J and SI Appendix, Fig. S14 F and G). The gene discussed is NCOA3; the disease is breast neoplasm.